Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 3,410 shares at $267.99 ($906K) on 2026-08-03, disclosed to the SEC on 2026-08-05.
Scheduled sale ($906k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $259.98 | 300 | $78K | 8.6% |
| 2 | $261.49 | 200 | $52K | 5.8% |
| 3 | $263.94 | 947 | $250K | 27.6% |
| 4 | $265.27 | 192 | $51K | 5.6% |
| 5 | $267.79 | 1,233 | $330K | 36.5% |
| 6 | $267.99 | 410 |
| $110K |
| 12.1% |
| 7 | $268.70 | 128 | $34K | 3.8% |
| Total | $265.58 avg | 3,410 | $906K | 100% |
| Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |
| NTRA | SELL | 2026-06-03 | $655K | — | Filing → |